Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. It uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.
종목 코드 ACON
회사 이름Aclarion Inc
상장일Apr 22, 2022
CEOMr. Brent Ness
직원 수6
유형Ordinary Share
회계 연도 종료Apr 22
주소8181 Arista Place
도시BROOMFIELD
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호80021
전화18332752266
웹사이트https://aclarion.com/
종목 코드 ACON
상장일Apr 22, 2022
CEOMr. Brent Ness
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음